tm
Seeing Is Believing
tm
Seeing Is Believing
CBAY is currently covered by 7 analysts with an average potential upside of $4.9 (53.78%) backed by displayed 37 price targets and 64 ratings.
Analysts average stock forecasts to be materialized ratio is 74.45% with an average time for these price targets to be met of 315.23 days.
Highest price target for CBAY is 16, Lowest price target is 2, average price target is 9.
Most recent stock forecast was given by STEVEN SEEDHOUSE from RAYMOND JAMES on 08-Nov-2023. First documented stock forecast 22-Jun-2017.
Currently, out of the existing stock ratings of CBAY - 14 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
34
$14.87 (77.73%)
17
23 days ago
6/8 (75%)
$6.9 (65.32%)
935
Buy
24
$4.87 (25.46%)
15
23 days ago
2/3 (66.67%)
$4.98 (39.40%)
61
Buy
33
$13.87 (72.50%)
12
25 days ago
5/6 (83.33%)
$5.06 (52.04%)
437
Buy
21
$6.09 (40.85%)
21
2 months 24 days ago
3/7 (42.86%)
$5.2 (45.48%)
79
Buy
18
$-1.13 (-5.91%)
3 months 17 days ago
2/2 (100%)
$3.38 (34.38%)
89
What is CBAY (CymaBay Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CBAY (CymaBay Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CBAY (CymaBay Therapeutics)?
Which analyst is the currently most bullish on CBAY (CymaBay Therapeutics)?
Which analyst is the currently most reserved on CBAY (CymaBay Therapeutics)?
